Efficacy of cefmetazole in the treatment of active syphilis in the rabbit model
Related Experiment Videos
S A Baker-Zander1, S A Lukehart
1Department of Medicine, University of Washington, Seattle 98195.
Abstract:
Cefmetazole, a cephamycin-type antibiotic, was shown to be as effective as standard benzathine penicillin for therapy of active syphilis in the rabbit model. Four groups of six adult male rabbits were inoculated intradermally with 10(6) Treponema pallidum per site, producing primary syphilitic lesions. One week following infection, groups of rabbits were treated with benzathine penicillin (200,000 U intramuscularly weekly for 2 weeks) or cefmetazole (20 or 40 mg/kg per day intramuscularly in four divided doses for 15 days); one group was untreated. Daily dark-field microscopic examination of lesion aspirates demonstrated that the mean times to dark-field negativity were the same for benzathine penicillin- and two cefmetazole-treated groups (1.0. 1.0, and 1.17 days, respectively), while all untreated animals remained dark-field positive for greater than 15 days. Mean maximum lesion diameters in cefmetazole-treated animals (8.7 +/- 1.3 and 8.1 +/- 1.3 mm) were equivalent to those in penicillin-treated animals (8.6 +/- 1.6 mm) and were smaller than observed in untreated animals (12.4 +/- 2.2 mm; P less than 0.01); fewer lesions ulcerated in penicillin- or cefmetazole-treated rabbits than in untreated rabbits (P less than 0.001). Persistent infection was documented in lymph nodes of untreated rabbits; no evidence of latent infection was found in penicillin- or cefmetazole-treated animals.
Insights
Cefmetazole, a cephamycin antibiotic, demonstrated efficacy comparable to benzathine penicillin in treating rabbit syphilis. This study highlights cefmetazole as a potential alternative for syphilis therapy.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Syphilis remains a significant global health concern.
- Benzathine penicillin is the standard treatment for syphilis.
- Alternative therapeutic options are needed to combat potential resistance and improve patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of cefmetazole, a cephamycin-type antibiotic, against active syphilis.
- To compare cefmetazole's effectiveness with standard benzathine penicillin therapy in a rabbit model.
Main Methods:
- Adult male rabbits were intradermally inoculated with Treponema pallidum.
- Infected rabbits were treated with benzathine penicillin or cefmetazole (two dosages).
- Lesion aspirates were examined daily using dark-field microscopy; lesion diameters and ulceration were recorded.
Main Results:
- Cefmetazole achieved dark-field negativity in lesion aspirates at a similar rate to benzathine penicillin.
- Mean maximum lesion diameters were comparable between cefmetazole- and penicillin-treated groups.
- Fewer lesions ulcerated, and no latent infection was detected in cefmetazole-treated rabbits.
Conclusions:
- Cefmetazole is as effective as benzathine penicillin for treating active syphilis in the rabbit model.
- Cefmetazole represents a promising alternative antibiotic for syphilis therapy.
- Further clinical studies are warranted to confirm cefmetazole's efficacy in human syphilis treatment.